Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Proof of Principle Study to Explore the Utility of Guaifenesin in Upper Back Pain

NCT01562548 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01562548
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01562548 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Proof of Principle Study to Explore the Utility of Guaifenesin in Upper Back Pain
Lead sponsor
GlaxoSmithKline
Phase
Not applicable
Overall status
Completed
Start date
February 29, 2012
Completion date
May 31, 2013
Enrollment
78 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

upper back pain